With China becoming increasingly competitive for device makers, Boston Scientific (Natick, Massachusetts) has set up a new research center to seek out innovations and better tailor products to the market.

As many as three-quarters of Chinese hospitals are expanding or upgrading their infrastructure and this will give medical device companies with the right market reach an enormous opportunity over the next decade or more.

SHANGHAI – When it went public in April 2007, Simcere Pharmaceutical Group quickly became the largest Chinese pharmaceutical listed in the U.S. Despite a good early performance, the stock never lived up to its promise. The firm’s share price crashed to below $5 after the global financial crisis and has been lingering at below $10 since late 2011 . Simcere, originally a maker of generics that has expanded into biologicals, will go private before the end of the year.